15-Year Follow-up of a Multicenter, Randomized, Calcineurin Inhibitor Withdrawal Study in Kidney Transplantation-Reference-Cited by-同舟云学术

15-Year Follow-up of a Multicenter, Randomized, Calcineurin Inhibitor Withdrawal Study in Kidney Transplantation

Published:2014-07-15 Issue:1 Volume:98 Page:47-53
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Roodnat Joke I.,Hilbrands Luuk B.,Hené Ronald J.,de Sévaux Ruud G.L.,Smak Gregoor Peter J.H.,Kal-van Gestel Judith A.,Konijn Cynthia,van Zuilen Arjan,van Gelder Teun,Hoitsma Andries J.,Weimar Willem

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.;Lancet,1983

2. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection.;Lancet,1995

3. Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.;Ekberg;Am J Transplant,2009

4. ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation.;Ekberg;N Engl J Med,2007

5. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.;Weir;Kidney Int,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left Ventricular Hypertrophy After Renal Transplantation: Systematic Review and Meta-analysis;Transplantation Direct;2024-05-17

2. Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?;International Journal of Molecular Sciences;2023-01-16

3. The aging of the immune system and its implications for transplantation;GeroScience;2023-01-10

4. Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients;Frontiers in Immunology;2022-11-28

5. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08